MedPath

Effects of Cardiac Rehabilitation and Respiratory Capacity and Physical Behavior of Oxygen Consumption in Cardiac Patients

Not Applicable
Recruiting
Conditions
I25.1
C14.280.647
Ischemic heart disease
Registration Number
RBR-7x429s
Lead Sponsor
Hospital do Coração - HCor - Instituto de Ensino e Pesquisa (I.E.P.)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Patients with ischemic cardiomyopathy with an ejection fraction of the left ventricle than or equal to 35% of both sexes. The minimum age of 18 years and maximum 90 years.

Exclusion Criteria

Functional limitations not related to the cardiovascular system. Such as disabling lung diseases and tumors of advanced degree.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increased tolerance of exercise time during constant workload test (in minutes) and shorter duration of oxygen uptake kinetics (tau, an indirect marker of oxidative metabolism) in seconds. It is estimated, after 3 months supervised physical training an increase of at least 10% in the time in minutes (min) exercise tolerance and a reduction of at least 5% at time kinetics in seconds (s), based on previous studies using other types of intervention such as drugs or percutaneous cardiac intervention (PCI).
Secondary Outcome Measures
NameTimeMethod
Increase in aerobic power (a measure of maximum oxygen consumption in L/min and ml.kg.min-1, the ventilatory efficiency (ratio of minute ventilation over carbon dioxide production (VE/VCO 2) and indexes of quality of life in the various fields extracted from the SF 36 questionnaire (Short Form 36).;Increased quality of life assessed by SF 36 which shows a final score ranging from 0 to 100, where 0 is the worst overall health status and 100 the best. It is expected an increase in the score of this general health questionnaire.
© Copyright 2025. All Rights Reserved by MedPath